Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 2/2006

01-03-2006 | Featured Review Article

Behavioral Interventions for HIV-Positive and HCV-Positive Drug users

Authors: Steffanie A. Strathdee, Thomas L. Patterson

Published in: AIDS and Behavior | Issue 2/2006

Login to get access

Abstract

The nature, context and frequency of use of various licit and illicit non-injection drugs associated with an elevated risk of HIV infection. Beyond HIV, a high proportion of HIV-infected IDUs are co-infected with HCV (hepatitis C virus). In this review, we provide a brief review of the epidemiology of these problems, discuss behavioral interventions that can reduce ongoing high risk behaviors among HIV-seropositive IDUs and MSM-DUs, and review the literature which has evaluated their effectiveness. The majority of these interventions have focused on HIV-seronegative heterosexuals and therefore need to be considered in this larger context; however, where possible we discuss the potential impact of these interventions among HIV-seropositive persons. In addition, we briefly discuss interventions which have the potential to simultaneously reduce ongoing transmission of both HIV and HCV. Finally, given the dearth of information on the effectiveness of behavioral interventions in reducing the burden of the HIV and HCV epidemics among persons already infected with either or both viruses, we describe some newer, promising interventions and offer suggestions for future studies.
Literature
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R., and Margolis, H. S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine, 341, 556–562.CrossRefPubMed
Altice, F. L., Mezger, J. A., Hodges, J., Bruce, R. D., Marinovich, A., Walton, M., Springer, S. A., and Friedland, G. H. (2004). Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication. Clinical Infectious Diseases, 38, S376–S387.CrossRefPubMed
Auerbach, J. D., and Coates, T. J. (2000). HIV prevention research: accomplishments and challenges for the third decade of AIDS. American Journal of Public Health, 90, 29–32.
Ball, A. L. (2002). Overview: Policies and interventions to stem HIV-1 epidemics associated with injecting drug use. In G. Stimson, D. C. Des Jarlais, and A. Ball (Eds.), Drug Injecting and HIV Infection: Global Dimensions and Local Responses (pp. 201–232). London: UCL Press.
Ball, J. C., Lange, W. R., Myers, C. P., and Friedman, S. R. (1988). Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior, 29, 214–226.PubMedCrossRef
Bastos, F. I., and Strathdee, S. A. (2000). Evaluating Effectiveness of Syringe Exchange Programmes: Current Issues and Future Prospects. Social Science & Medicine, 51, 1771–1782.CrossRef
Beckett, M., Burnam, A., Collins, R. L., Kanouse, D. E., and Beckman, R. (2003). Substance use and high-risk sex among people with HIV: a comparison across exposure groups. AIDS and Behavior, 7, 209–219.CrossRefPubMed
Benotsch, E. G., Kalichman, S., and Cage, M. (2002). Men who have met sex partners via the Internet: prevalence, predictors, and implications for HIV prevention. Archives of Sexual Behavior, 31, 177–183CrossRefPubMed
Bluthenthal, R. N., Kral, A. H., Gee, L., Erringer, E. A., and Edlin, B. R. (2000). The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS, 14, 605–611.CrossRefPubMed
Booth, R. E., Crowley, and Zhang, Y. (1996). Substance abuse treatment entry, retention, and effectiveness: out-of-treatment opiate injection drug users. Drug and Alcohol Dependence, 42, 11–20CrossRefPubMed
Brooks, J. S., Nomura, C., and Cohen, P. (1989). A network of influences on adolescent drug users involvement: Neighborhood, school, peer, and family. Genetic, Social, and General Psychology Monographs, 115, 125–145.
Brooner, R., Kidorf, M., King, V., Beilenson, P., Svikis, D., and Vlahov, D. (1998). Drug abuse treatment success among needle exchange participants. Public Health Reports, 113, 129–39.PubMed
Bruneau, J., Lamothe, F., Franco, E., Lachance, N., Desy, M., Soto, J., and Vincelette, J. (1997). High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. American Journal of Epidemiology, 146, 994–1002.PubMed
Bull, S. S., Piper, P., and Rietmeijer, C. (2002). Men who have sex with men and also inject drugs-profiles of risk related to the synergy of sex and drug injection behaviors. Journal of Homosexuality, 42, 31–51.CrossRefPubMed
Buning, E. C., Coutinho, R. A., van Brussel, G. H., van Santen, G. W., and van Zadelhoff, A. W. (1986). Preventing AIDS in drug addicts in Amsterdam. Lancet, 1, 1435.CrossRefPubMed
Carrieri, M. P., Rey, D., Loundou, A., Lepeu, G., Sobel, A., Obadia, Y., and The MANIF-2000 Study Group (2003). Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users. Drug and Alcohol Dependence, 72, 13–21.CrossRefPubMed
Catania, J. A., Morin, S. F., Canchola, J., Pollack, L., Chang, J., and Coates, T. J. (2000). Health care policy. U.S. priorities-HIV prevention. Science, 290, 717.CrossRefPubMed
Celentano, D. D., Galai, N., Sethi, A. K., Shah, N. G., Strathdee, S. A., Vlahov, D., and Gallant, J. E. (2001). Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS, 15, 1707–15.CrossRefPubMed
Celentano, D. D., Vlahov, D., Cohn, S., Anthony, J. C., Solomon, L., and Nelson, K. E. (1991). Risk factors for shooting gallery use and cessation among intravenous drug users. American Journal of Public Health, 81, 1291–1295.PubMed
Celentano, D. D., Vlahov, D., Cohn, S., Shadle, V. M., Obasanjo, O., and Moore, R. D. (1998). Self-reported antiretroviral therapy in injection drug users. The Journal of the American Medical Association, 280, 544–6.CrossRef
Chiasson, M. A., Stoneburner, R. L., Hildebrandt, D. S., Ewing, W. E., Telzak, E. E., and Jaffe, H. W. (1991). Heterosexual transmission of HIV-1 associated with the use of smokeable freebase cocaine (crack). AIDS, 9, 1121–1126.CrossRef
Chng, C. L., and Geliga-Vargas, J. (2000). Ethnic identity, gay identity, sexual sensation seeking and HIV risk taking among multiethnic men who have sex with men. AIDS Education and Prevention, 12, 326–339.PubMed
Chu, P. L., McFarland, W., Gibson, S., Weide, D., Henne, J., Miller, P., Partridge, T., and Schwarcz, S. (2003). Viagra use in a community-recruited sample of men who have sex with men, San Francisco. Journal of Acquired Immune Deficiency Syndrome, 33, 191–3.CrossRef
Cleary, P. D., Van Devanter, N., Steilen, M., Stuart, A., Shipton-Levy, R., McMullen, W., Rogers, T. F., Singer, E., Avorn, J., and Pindyck, J. (1995). A randomized trial of an education and support program for HIV-infected individuals. AIDS, 9, 1271–1278.PubMedCrossRef
Conway, B., Prasad, J., Reynolds, R. et. al. (2004). Directly Observed Therapy for the Management of HIV Infected Patients in a Methadone Program. Clinical Infectious Diseases, 38, S402–S408.CrossRefPubMed
Copenhaver, M., Avants, S. K., Warburton, L. A., and Margolin, A. (2003). Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment. Journal of Psychoactive Drugs, 35, 209–18.PubMed
Crawford, I., Hammack, P. L., McKirnan, D. J., Ostrow, D., Zamboni, B. D., Robinson, B., and Hope, B. (2003). Sexual sensation seeking, reduced concern about HIV and sexual risk behaviour among gay men in primary relationships. AIDS Care, 15, 513–24.CrossRefPubMed
Crofts, N., Nigro, L., Oman, K., Stevenson, E., and Sherman, J. (1997). Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction, 92, 999–1005.CrossRefPubMed
Cross, J. E., Saunders, C. M., and Bartelli, D. (1998). The effectiveness of educational and needle exchange programs: a meta-analysis of HIV prevention strategies for injecting drug users. Quality and Quantity, 32, 165–180.CrossRef
Deren, S., Beardsley, M., Tortu, S., and Goldstein, M. F. (1998). HIV serostatus and changes in risk behaviors among drug injectors and crack users. AIDS and Behavior, 2, 171–176.CrossRef
Des Jarlais, D. C. (1989). AIDS prevention programs for intravenous drug users: Diversity and evolutions. International Review of Psychiatry, 1, 101–108.CrossRef
Des Jarlais, D. C., Hagan, H., Friedman, S. R., Friedmann, P., Goldberg, D., Frischer, M., Green, S., Tunving, K., Ljungberg, B., Wodak, A., et al. (1995). Maintaining low HIV seroprevalence in populations of injecting drug users. The Journal of the American Medical Association, 274, 1226–1231.CrossRef
Des Jarlais, D. C., Marmor, M., Friedmann, P., Titus, S., Aviles, E., Deren, S., Torian, L., Glebatis, D., Murrill, C., Monterroso, E., and Friedman, S. R. (2000). HIV incidence among injection drug users in New York City, 1992–1997: evidence for a declining epidemic. American Journal of Public Health, 90, 352–359.PubMed
Des Jarlais, D. C., Perlis, T., Arasteh, K., Hagan, H., Milliken, J., Braine, N., Yancovitz, S., Mildvan, D., Perlman, D. C., Maslow, C., and Friedman, S. R. (2004). Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. Journal of Acquired Immune Deficiency Syndromes, 35, 158–166.PubMedCrossRef
Diamond, C., Thiede, H., Perdue, T., Secura, G. M., Valleroy, L., Mackellar, D., Corey, L. and Seattle Young Men's Survey Team. (2003). Viral hepatitis among young men who have sex with men: prevalence of infection, risk behaviors, and vaccination. Sexually Transmitted Diseases, 30, 425–32.CrossRefPubMed
DiScenza, S., Nies, M., and Jordan, C. (1996). Effectiveness of counseling in the health promotion of HIV-positive clients in the community. Public Health Nursing, 13, 209–216.PubMedCrossRef
Dolezal, C., Carballo-Dieguez, A., Nieves-Rosa, L., and Diaz, F. (2000). Substance use and sexual risk behavior: understanding their association among four ethnic groups of Latino men who have sex with men. Journal of Substance Abuse, 11, 323–36.CrossRefPubMed
Drucker, E., Lurie, P., Wodak, A., and Alcabes, P. (1998). Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS, 12, S217–S230.CrossRefPubMed
Edlin, B. R., Irwin, K. L., Faruque, S., McCoy, C. B., Word, C., Serrano, Y., Inciardi, J. A., Bowser, B. P., Schilling, R. F., and Holmberg, S. D. (1994). Intersecting epidemics—crack cocaine use and HIV infection among inner-city young adults. New England Journal of Medicine, 331, 1422–1427.CrossRefPubMed
Elliot, D. S., Huizinga, D., and Ageton, S. S. (1985). Explaining delinquency and drug use. Beverly Hills, CA: Sage.
Fisher, J. D., and Fisher, W. A. (1992). Changing AIDS risk behavior. Psychological Bulletin, 111, 455–474.CrossRefPubMed
Fisher, J. D., and Misovich, S. J. (1990). Social influence and AIDS-preventive behaviors. In J. Edwards, R. Tindale, L. Heath, and E. Posavac (Eds.), Applying social influence processes in preventing social problems (pp. 39–70). New York: Plenum Press.
Friedman, S. R., Des Jarlais, D. C., Sotheran, J. L., Garber, J., Cohen, H., and Smith, D. (1987). AIDS and self- organization among intravenous drug users. The International Journal of the Addictions, 23, 201–219.
Friedman, S. R., Jose, B., Neaigus, A., Goldstein, M., Curtis, R., Ildefonso, G., Mota, P., and Des Jarlais, D. C. (1994). Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs. AIDS, 8, 357–61.PubMedCrossRef
Galvan, F. H., Burnam, M. A., and Bing, E. G. (2003). Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. Journal of Psychoactive Drugs, 35, 153–60.PubMed
Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., and Vlahov, D. (1998). Prevalence and incidence of hepatitis C virus infection among young adults injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 8, S11–S19.
Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., and Nelson, K. E. (1996). Viral infections in short-term injection drug users; the prevalence of the hepatitis C, hepatitis B, human immunodeficiency virus, and human T-lymphotropic virus. American Journal of Public Health, 86, 655–661.PubMedCrossRef
Gerberding, J. (1995). Management of occupational exposure to blood borne viruses. New England Journal of Medicine, 332, 444–451.CrossRefPubMed
Gordon, C. M., Stall, R., and Cheever, L. W. (2004). Prevention interventions with persons living with HIV/AIDS: Challenges, Progress, and Research Priorities. Journal of acquired immune deficiency syndromes, 37, S53–S57.PubMedCrossRef
Greenblatt, J. C., and Gfoerer, J. C. (1996). Methamphetamine abuse in the United States. Analysis of Substance Abuse and Treatment Need Issues. Rockville, MD: Substance Abuse and Mental Health Services Administration.
Hagan, H., and Des Jarlais, D. C. (2000). HIV and HCV infection among injecting drug users. The Mount Sinai Journal of Medicine, 67, 423–8.
Hagan, H., DesJarlais, D. C., Friedman, S. R., Purchase, D., and Alter, M. J. (1995). Reduced risk of Hepatitis B and Hepatitis C among injection drug users in the Tacoma Syringe Exchange Program. American Journal of Public Health, 1531–1537.
Hahn, J. A., Vranizan, K. M., and Moss, A. R. (1997). Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989–1990. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15, 157–64.PubMed
Halkitis, P. N., Parsons, J. T., and Wilton, L. (2003). Barebacking among gay and bisexual men in New York City: explanations for the emergence of intentional unsafe behavior. Archives of Sexual Behavior, 32, 351–7.CrossRefPubMed
Heimer, R. (1998). Can syringe exchange serve as a conduit to substance abuse treatment? Journal of Substance Abuse Treatment, 15, 183–91.CrossRefPubMed
Heimer, R., Khoshnood, K., Bigg, D., Guydish, J., and Jungue, B. (1998). Syringe use and reuse: effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S37.PubMed
Holmberg, S. D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health, 86, 643–654.
Hubbard, R. L., Marsden, M. E., Cavanaugh, E., Rachal, J. V., and Ginzburg, H. M. (1988). Role of drug-abuse treatment in limiting the spread of AIDS. Reviews of Infectious Diseases, 10, 377–84.PubMed
Janssen, R. S., Holtgrave, D. R., Valdiserri, R. O., Shepherd, M., Gayle, H. D., and De Cock, K. M.(2001). The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals. American Journal of Public Health, 91, 1019–1024.PubMed
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., and Bigelow, G. E. (2000). A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine, 343, 1290–1297.CrossRefPubMed
Johnson, W. D., Hedges, L. V., Ramirez, G., Semaan, S., Norman, L. R., Sogolow, E., Sweat, M. D., and Diaz, R. M. (2002). HIV prevention research for men who have sex with men: A systematic review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 30, S118–S129.PubMed
Kalichman, S. C., Heckman, T., and Kelly, J. A. (1996). Sensation seeking as an explanation for the association between substance use and HIV-related risky sexual behavior. Archives of Sexual Behavior, 25, 141–54.PubMedCrossRef
Kalichman, S. C., Kelly, J. A., and Rompa, D. (1997). Continued high-risk sex among HIV seropositive gay and bisexual men seeking HIV prevention services. Health Psychology, 16, 369–373.CrossRefPubMed
Kalichman, S. C., Rompa, D., Cage, M., DiFonzo, K., Simpson, D., Austin, J., Luke, W., Buckles, J., Kyomugisha, F., Benotsch, E., Pinkerton, S., and Graham, J. (2001). Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. American Journal of Preventive Medicine, 21, 84–92.CrossRefPubMed
Kalichman, S. C., Weinhardt, L., DiFonzo, K., Austin, J., and Luke, W. (2002). Sensation seeking and alcohol use as markers of sexual transmission risk behavior in HIV-positive men. Annals of Behavioral Medicine, 24, 229–35.CrossRefPubMed
Kim, A. A., Kent, C., McFarland, W., and Klausner, J. D. (2001). Cruising on the Internet highway. Journal of Acquired Immune Deficiency Syndrome, 28, 89–93.
Kosten, T., Oliveto, A., Feingold, A., Poling, J., Sevarino, K., McCance-Katz, E., Stine, S., Gonzalez, G., and Gonsai, K. (2003). Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug and Alcohol Dependence, 70, 315–325CrossRefPubMed
Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., and Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet, 357, 1397–1401.CrossRefPubMed
Langendam, M. W., van Brussel, G. H., Coutinho, R. A., and van Ameijden, E. J. (1999). Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study. AIDS, 13, 1711–1716.CrossRefPubMed
Latkin, C. A., Forman, V., Knowlton, A., Hoover, D., Hatcher, M., and Celentano, D. D. (2001). Injection Drug Users' Disclosure of HIV Seropositive Status to Network Members. AIDS and Behavior, 5, 297–305.CrossRef
Latkin, C. A., Forman-Hoffman, V. L., D'Souza, G., and Knowlton, A. R. (2004). Associations between medical service use and HIV risk among HIV-positive drug users in Baltimore, MD. AIDS Care, 16, 901–908.CrossRefPubMed
Latkin, C. A., Sherman, S. G., and Knowlton, A. (2003). HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Health Psychology, 22, 332–339.CrossRefPubMed
Lau, J. T., Kim, J. H., Lau, M., and Tsui, H. Y. (2003). Prevalence and risk behaviors of Chinese men who seek same-sex partners via the internet in Hong Kong. AIDS Education and Prevention, 15, 516–28.CrossRefPubMed
Leigh, B. C. (2002). Alcohol and condom use: a meta-analysis of event-level studies. Sexually Transmitted Diseases, 29, 476–82.CrossRefPubMed
Loughlin, A., and Strathdee, S. A. (In Press). Hepatitis C infection among drug users enrolled in methadone maintenance program. The International Journal on Drug Policy.
Lucas, G. M., Cheever, L. W., Chaisson, R. E., and Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 27, 251–259.PubMed
Lucas, G. M., Weidle, P. J., Hader, S., Moore, R. D. (2004). Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. Clinical Infectious Diseases, 38, S409–S413.CrossRefPubMed
Lurie, P., Gorsky, R., Jones, T. S., and Shomphe, L. (1998). An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S126–S132.PubMed
Macalino, G. E., Mitty, J. A., Bazerman, L. B., Singh, K., McKenzie, M., and Flanigan, T. (2004). Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot study. Clinical Infectious Diseases, 38, S393–S397.CrossRefPubMed
MacGowan, R. J., Brackbill, R. M., Rugg, D. L., Swanson, N. M., Weinstein, B., Couchon, A., Scibak, J., Molde, S., McLaughlin, P., Barker, T., and Voigt, R. (1997). Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New England. AIDS, 11, 229–35.CrossRefPubMed
Marmor, M., Friedman-Kien, A. E., Laubenstein, L., Byrum, R. D., William, D. C., D'Onofrio, S., and Dubin, N. (1982). Risk factors for Kaposi's sarcoma in homosexual men. Lancet, 15, 1083–7.CrossRef
Mattison, A. M., Ross, M. W., Wolfson, T., Franklin, D., and the HIV Neurobehavioral Research Center Group (2001). Circuit party attendance, club drug use, and unsafe sex in gay men. Journal of Substance Abuse, 13, 119–26.CrossRefPubMed
McCance-Katz, E. F., Rainey, P. M., Friedland, G., and Jatlow, P. (2003). The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. Clinical Infectious Diseases, 37, 476–82.CrossRefPubMed
McCance-Katz, E. F., Rainey, P. M., Jatlow, P., and Friedland, G. (1998). Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, 435–43.PubMed
McCusker, J., Stoddard, A. M., Hindin, R. N., Garfield, F. B., and Frost, R. (1996). Changes in HIV risk behavior following alternative residential programs of drug abuse treatment and AIDS education. Annals of Epidemiology, 6, 119–125.CrossRefPubMed
McMahon, R. C., Malow, R. M., Jennings, T. E., and Gomez, C. J. (2001). Effects of a cognitive-behavioral HIV prevention intervention among HIV negative male substance abusers in VA residential treatment. AIDS Education and Prevention, 13, 91–107.CrossRefPubMed
Meandzija, B., O'Connor, P. G., Fitzgerald, B., Rounsaville, B. J., and Kosten, T. R. (1994). HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug and Alcohol Dependence, 36, 109–13.CrossRefPubMed
Metsch, L. R., McCoy, C. B., Lai, S., and Miles, C. (1998). Continuing risk behaviors among HIV-seropositive chronic drug users in Miami, Florida. AIDS and Behavior, 2, 161–169.CrossRef
Metsch, L. R., Pereyra, M., and Brewer, T. H. (2001). Use of HIV health care in HIV-seropositive crack cocaine smokers and other active drug users. Journal of Substance Abuse, 13, 155–67.CrossRefPubMed
Metzger, D. S., and Navaline, H. (2003). Human immunodeficiency virus prevention and the potential of drug abuse treatment. Clinical Infectious Diseases, 37, S451–S456.CrossRefPubMed
Metzger, D. S., Woody, G. E., McLellan, A. T., O'Brien, C. P., Druley, P., Navaline, H., DePhilippis, D., Stolley, P., Abrutyn, E. (1993). Human immunodeficiency virus seroconversion among in- and out-of-treatment intravenous drug users: an 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes, 6, 1049–1056.PubMed
National Commission on AIDS. (1991). The twin epidemics of substance abuse and HIV. Washington, DC: National Commission on AIDS.
National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. (1998). Effective medical treatment of opiate addiction. Journal of the American Medical Association, 280, 1936–1943.CrossRef
NIH Consensus Statement. (1997). Interventions to prevent HIV risk behaviors. 15, 1–41
Normand, J., Vlahov, D., and Moses, L. E. (1995). Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press.
Office of the Surgeon General. (2000). Evidence-based findings on the efficacy of syringe exchange programs: an analysis from the Assistant Secretary for Health and Surgeon General of the scientific research completed since April 1998. Washington, DC: Office of the Surgeon General. http://​www.​harmreduction.​org/​surgreview.​html.
Ompad, D. C., Fuller, C. M., Vlahov, D., Thomas, D., and Strathdee, S. A. (2002). Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clinical Infectious Diseases, 35, 783–788.CrossRefPubMed
Ostrow, D. E., Fox, K. J., Chmiel, J. S., Silvestre, A., Visscher, B. R., Vanable, P. A., Jacobson, L. P., and Strathdee, S. A. (2002). Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS, 16, 775–780.CrossRefPubMed
Palepu, A., Tyndall, M. W., Li, K., Yip, B., O'Shaughnessy, M. V., Schechter, M. T., Montaner, J. S., and Hogg, R. S. (2003). Alcohol Use and Incarceration Adversely Affect HIV-1 RNA Suppression Among Injection Drug Users Starting Antiretroviral Therapy. Journal of Urban Health, 80, 667–75.PubMed
Parsons, J. T., and Halkitis, P. N. (2002). Sexual and drug-using practices of HIV-positive men who frequent public and commercial sex environments. AIDS Care, 14, 815–26.CrossRefPubMed
Parsons, J. T., Huszti, H. C., Crudder, S. O., Rich, L., and Mendoza, J. (2000). Maintenance of safer sexual behaviours: Evaluation of a theory-based intervention for HIV seropositive men with hemophilia and their female partners. Hemophilia, 6, 181–197.CrossRef
Patterson, T. L., and Semple, S. J. (2002). Reducing the Sexual Risk Behaviors of HIV-positive Individuals: Outcome of a Randomized Controlled Trial. Annals of Behavioral Medicine, 25.
Prendergast, M. L., Urada, D., and Podus, D. J. (2001). Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. Journal of Consulting and Clinical Psychology, 69, 389–405.CrossRefPubMed
Purcell, D. W., Metsch, L. R., Latka, M., Santibanez, S., and Gomez, C. A., Eldred, L., and Latkin, C. A. (2004). Interventions for seropositive injectors - Research and evaluation - An integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. Journal of Acquired Immune Deficiency Syndromes, 37, S110–S118.PubMedCrossRef
Rhodes, T., and Hartnoll, R. (1996). AIDS, Drugs, and Prevention: Perspectives on Individual and Community Action. London: Routledge.
Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., Wolfson, T., Grant, I., and the HNRC group. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10, 1–14.CrossRefPubMed
Robles, R. R., Marrero, C. A., Reyes, J. C., Colon, H. M., Matos, T. D., Finlinson, H. A., Munoz, A., Melendez, M., and Sahai, H. (1998). Risk behaviors, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 17, 477–83.PubMed
Ross, M. W., Mattison, A. M., and Franklin, D. R. (2003). Club drugs and sex on drugs are associated with different motivations for gay circuit party attendance in men. Substance Use & Misuse, 38, 1173–83.CrossRef
Schechter, M. T., Strathdee, S. A., Cornelisse, P. G., Currie, S., Patrick, D. M., Rekart, M. L., and O'Shaughnessy, M. V. (1999). Do needle exchange programmes increase the spread of HIV among injection drug users?: An investigation of the Vancouver outbreak. AIDS, 13, F45–F51CrossRefPubMed
Semaan, S., Des Jarlais, D. C., Sogolow, E., Johnson, W. D., Hedges, L. V., Ramirez, G., Flores, S. A., Norman, L., Sweat, M. D., and Needle, R. (2002). A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. Journal of Acquired Immune Deficiency Syndromes, 30, S73–S93.CrossRefPubMed
Semple, S. J., Patterson, T. L., and Grant, I. (2003). Binge Use of Methamphetamine Among HIV-positive Men Who Have Sex With Men: Pilot Data And HIV Prevention Implications. AIDS Education and Prevention, 15, 133–147CrossRefPubMed
Shah, N., Celentano, D. D., Vlahov, D., Stambolis, V., Johnson, L., Nelson, K. E., and Strathdee, S. A. (2000). Correlates of enrollment in methadone maintenance programs differ by HIV-serostatus. AIDS, 14, 2035–43.CrossRefPubMed
Stimson, G. V., and Choopanya, K. (1998). Global Perspectives on Drug Injecting. In G. V. Stimson, D. C. Des Jarlais, A. Ball (Eds.), Drug Injecting and HIV Infection: Global Dimensions and Local Responses (Social Aspects of AIDS) (pp.1–21). London: UCL Press.
Strathdee, S. A., Celentano, D. D., Shah, N., Lyles, C., Macalino, G., Nelson, K., and Vlahov, D. (1999). Needle Exchange Attendance and Health Care Utilization Promote Entry into Detoxification. Journal of Urban Health, 76, 448–460.CrossRefPubMed
Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., and Nelson, K. E. (2001). Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Archives of Internal Medicine, 161, 1281–8.CrossRefPubMed
Strathdee, S. A., Palepu, A., Cornelisse, P. G. A., Yip, B., O'Shaughnessy, M. V., Montaner, J. S. T., Schechter, M. T., and Hogg, R. S. (1998). Barriers to utilization of antiretroviral therapies among HIV-infected injection drug users in a universal health care setting. Journal of American Medical Association, 280, 547–549.CrossRef
Strathdee, S. A., Patrick, D. M., Archibald, C. P., Ofner, M., Cornelisse, P. G. A., Rekart, M. L., Schechter, M. T., and O'Shaughnessy, M. V. (1997). Social determinants predict needle sharing behaviour among injection drug users in Vancouver, Canada. Addiction, 92, 1339–1347.CrossRefPubMed
Strauss, S. M., Des Jarlais, D. C., Astone, J., and Vassilev, Z. P. (2003). On-site HIV testing in residential drug treatment units: results of a nationwide survey. Public Health Reports, 118, 37–43.PubMed
Sylvestre, D. L. (2002). Treating hepatitis C in methadone maintenance patients: an interim analysis. Drug and Alcohol Dependence, 67, 117–123.CrossRefPubMed
Sylvestre, D. L., Loftis, J. M., Hauser, P., Genser, S., Cesari, H., Borek, N., Kresina, T. F., Seeff, L., and Francis, H. (2004). Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. Journal of Urban Health, 81, 719–34.PubMed
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., Laeyendecker, O., Boitnott, J., Wilson, L. E., and Vlahov, D. (2000). The natural history of Hepatitis C virus infection: host, viral, and environmental factors. Journal of American Medical Association, 284, 450–456.CrossRef
Tun, W., Celentano, D. D., Vlahov, D., and Strathdee, S. A. (2003). Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS, 17, 1953–1962.CrossRefPubMed
Tyndall, M. W., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M. V., and Schechter, M. T. (2003). Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17, 887–93.CrossRefPubMed
U.S. General Accounting Office. (1993). Needle exchange programs: research suggests promise as an AIDS prevention strategy. Washington, DC: US Government Printing Office. (Publication no. GAO/HRD 93-60).
Valleroy, L. A., MacKellar, D. A., Karon, J. M., Rosen, D. H., McFarland, W., Shehan, D. A., Stoyanoff, S. R., LaLota, M., Celentano, D. D., Koblin, B. A., Thiede, H., Katz, M. H., Torian, L. V., and Janssen, R. S. (2000). HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. Journal of American Medical Association, 284, 198–204.CrossRef
van Ameijden, E. J., and Coutinho, R. A. (2001). Large decline in injecting drug use in Amsterdam, 1986–1998: explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology and Community Health, 55, 356–363CrossRefPubMed
van Beek, I., Dwyer, R., Dore, G. J., Luo, K., and Kaldor, J. M. (1998). Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. British Medical Journal, 317, 433–437.PubMed
van Empelen, P., Kok, G., van Kesteren, N. M., van den Borne, B., Bos, A. E., and Schaalma, H. P. (2003). Effective methods to change sex-risk among drug users: a review of psychosocial interventions. Social Science & Medicine, 57, 1593–608.CrossRef
Vastag, B. (2001). Ecstasy experts want realistic messages. Journal of the American Medical Association, 286, 777.CrossRefPubMed
Vertefeuille, J., Marx, M. A., Tun, W., Huettner, S., Strathdee, S. A., and Vlahov, D. (2000). Decline in Self-Reported High Risk Injection-Related Behaviors Among HIV Seropositive Participants in the Baltimore Needle Exchange Program. AIDS and Behavior, 4, 381–388.CrossRef
Vlahov, D., Junge, B., Brookmeyer, R., Cohn, S., Riley, E., Armenian, H., and Beilenson, P. (1997). Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 16, 400–406.
Warner, B. D., and Leukefeld, C. G. (2001). Assessing the differential impact of an HIV prevention intervention: who's putting the message into practice? AIDS Education and Prevention, 13, 479–94.CrossRefPubMed
Weinhardt, L. S., Otto-Salaj, L. L., Brondino, M. J., Norberg, M. M., and Kalichman, S. C. (2002). Sex-related alcohol expectancies predict sexual risk behavior among severely and persistently mentally ill adults. Psychology of Addictive Behaviors, 16, 64–7.CrossRefPubMed
Wolitski, R. J., Gomez, C. A., and Parsons, J. T. (2005a). Effects of a peer-led behavioral intervention to reduce HIV transmission and promote serostatus disclosure among HIV-seropositive gay and bisexual men. AIDS, 19, Suppl 1, S99–109.
Wolitski, R. J., Parsons, J. T., Gomez, C. A. Purcell, D. W., Hoff, C. C., and Halkitis, P. N. (2005b). Prevention with gay and bisexual men living with HIV: rationale and methods of the Seropositive Urban Men's Intervention Trial (SUMIT). AIDS, 19 Suppl 1, S1–11.
Woody, G. E., Donnell, D., Seage, G. R., Metzger, D., Marmor, M., Koblin, B. A., Buchbinder, S., Gross, M., Stone, B., and Judson, F. N. (1999). Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Drug & Alcohol Dependence, 53, 197–205.CrossRef
Metadata
Title
Behavioral Interventions for HIV-Positive and HCV-Positive Drug users
Authors
Steffanie A. Strathdee
Thomas L. Patterson
Publication date
01-03-2006
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2006
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-005-9055-5

Other articles of this Issue 2/2006

AIDS and Behavior 2/2006 Go to the issue

Original Article

Severity of Child Sexual Abuse, Post- Traumatic Stress and Risky Sexual Behaviors Among HIV-Positive Women

Commercial Sex Workers

Condom Use and Its Correlates Among Female Sex Workers in Hanoi, Vietnam

Other Research Articles

Predictors of Sexually Transmitted Infection Testing Among Sexually Active Homeless Youth

Other Research Articles

Additive Deleterious Effects of Methamphetamine Dependence and Immunosuppression on Neuropsychological Functioning in HIV Infection

Other Research Articles

Association of Violence Victimization with Inconsistent Condom Use in HIV-Infected Persons

Original Article

The Impact of Exposure to Transphobia on HIV Risk Behavior in a Sample of Transgendered Women of Color in San Francisco
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits